Literature DB >> 25527363

Three-dimensional modeling of the human fallopian tube fimbriae.

Sharon L Eddie1, Suzanne M Quartuccio1, Jie Zhu2, Jessica A Shepherd3, Rajul Kothari4, J Julie Kim2, Teresa K Woodruff2, Joanna E Burdette5.   

Abstract

OBJECTIVE: Ovarian cancer is the most lethal gynecological malignancy that affects women. Recent data suggests that the disease may originate in the fallopian fimbriae; however, the anatomical origin of ovarian carcinogenesis remains unclear. This is largely driven by our lack of knowledge regarding the structure and function of normal fimbriae and the relative paucity of models that accurately recapitulate the in vivo fallopian tube. Therefore, a human three-dimensional (3D) culture system was developed to examine the role of the fallopian fimbriae in serous tumorigenesis.
METHODS: Alginate matrix was utilized to support human fallopian fimbriae ex vivo. Fimbriae were cultured with factors hypothesized to contribute to carcinogenesis, namely; H2O2 (1mM) a mimetic of oxidative stress, insulin (5μg/ml) to stimulate glycolysis, and estradiol (E2, 10nM) which peaks before ovulation. Cultures were evaluated for changes in proliferation and p53 expression, criteria utilized to identify potential precursor lesions. Further, secretory factors were assessed after treatment with E2 to identify if steroid signaling induces a pro-tumorigenic microenvironment.
RESULTS: 3D fimbriae cultures maintained normal tissue architecture up to 7days, retaining both epithelial subtypes. Treatment of cultures with H2O2 or insulin significantly induced proliferation. However, p53 stabilization was unaffected by any particular treatment, although it was induced by ex vivo culturing. Moreover, E2-alone treatment significantly induced its canonical target PR and expression of IL8, a factor linked to poor outcome.
CONCLUSIONS: 3D alginate cultures of human fallopian fimbriae provide an important microphysiological model, which can be further utilized to investigate serous tumorigenesis originating from the fallopian tube.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fallopian tube; fimbriae; microphysiological modeling

Mesh:

Year:  2014        PMID: 25527363      PMCID: PMC4358821          DOI: 10.1016/j.ygyno.2014.12.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  32 in total

1.  Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.

Authors:  Weiwei Shan; Imelda Mercado-Uribe; Jing Zhang; Daniel Rosen; Shiwu Zhang; Jianjun Wei; Jinsong Liu
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

2.  Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.

Authors:  Amir A Jazaeri; Jennifer L Bryant; Hong Park; Hui Li; Neetu Dahiya; Mark H Stoler; James Stuart Ferriss; Anindya Dutta
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

Review 3.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

4.  Epithelial ovarian cancer risk among women with polycystic ovary syndrome.

Authors:  J M Schildkraut; P J Schwingl; E Bastos; A Evanoff; C Hughes
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

5.  The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?

Authors:  K Ivarsson; E Runesson; K Sundfeldt; M Haeger; L Hedin; P O Janson; M Brännström
Journal:  Gynecol Oncol       Date:  1998-12       Impact factor: 5.482

Review 6.  STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis.

Authors:  Karishma Mehra; Mitra Mehrad; Geng Ning; Ronny Drapkin; Frank D McKeon; Wa Xian; Christopher P Crum
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

7.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

8.  Ex vivo culture of primary human fallopian tube epithelial cells.

Authors:  Susan Fotheringham; Keren Levanon; Ronny Drapkin
Journal:  J Vis Exp       Date:  2011-05-09       Impact factor: 1.355

9.  In vitro three-dimensional modeling of fallopian tube secretory epithelial cells.

Authors:  Kate Lawrenson; Maria Notaridou; Nathan Lee; Elizabeth Benjamin; Ian J Jacobs; Christopher Jones; Simon A Gayther
Journal:  BMC Cell Biol       Date:  2013-09-27       Impact factor: 4.241

Review 10.  The Chemokine CXCL8 in Carcinogenesis and Drug Response.

Authors:  Dominique Gales; Clarence Clark; Upender Manne; Temesgen Samuel
Journal:  ISRN Oncol       Date:  2013-10-09
View more
  10 in total

Review 1.  Lessons from bioengineering the ovarian follicle: a personal perspective.

Authors:  Teresa K Woodruff
Journal:  Reproduction       Date:  2019-12       Impact factor: 3.906

Review 2.  Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.

Authors:  Zehong Yang; Hongyan Xu; Xiaojun Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-03-20       Impact factor: 16.806

3.  Correlation of clinical data with fallopian tube specimen immune cells and tissue culture capacity.

Authors:  Satish Kumar Ramraj; Katie M Smith; Naveena B Janakiram; Coralee Toal; Ankita Raman; Doris Mangiaracina Benbrook
Journal:  Tissue Cell       Date:  2018-04-04       Impact factor: 2.466

4.  Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models.

Authors:  Laura J Mauro; Megan I Seibel; Caroline H Diep; Angela Spartz; Carlos Perez Kerkvliet; Hari Singhal; Elizabeth M Swisher; Lauren E Schwartz; Ronny Drapkin; Siddharth Saini; Fatmata Sesay; Larisa Litovchick; Carol A Lange
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

Review 5.  Advancements in Microfluidic Systems for the Study of Female Reproductive Biology.

Authors:  Vedant V Bodke; Joanna E Burdette
Journal:  Endocrinology       Date:  2021-10-01       Impact factor: 4.736

6.  Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.

Authors:  Georgette Moyle-Heyrman; Matthew J Schipma; Matthew Dean; David A Davis; Joanna E Burdette
Journal:  J Ovarian Res       Date:  2016-02-15       Impact factor: 4.234

7.  Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium.

Authors:  Nur Yucer; Marie Holzapfel; Tilley Jenkins Vogel; Lindsay Lenaeus; Loren Ornelas; Anna Laury; Dhruv Sareen; Robert Barrett; Beth Y Karlan; Clive N Svendsen
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

8.  Periovulatory follicular fluid levels of estradiol trigger inflammatory and DNA damage responses in oviduct epithelial cells.

Authors:  Sergio E Palma-Vera; Jennifer Schoen; Shuai Chen
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

9.  A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle.

Authors:  Shuo Xiao; Jonathan R Coppeta; Hunter B Rogers; Brett C Isenberg; Jie Zhu; Susan A Olalekan; Kelly E McKinnon; Danijela Dokic; Alexandra S Rashedi; Daniel J Haisenleder; Saurabh S Malpani; Chanel A Arnold-Murray; Kuanwei Chen; Mingyang Jiang; Lu Bai; Catherine T Nguyen; Jiyang Zhang; Monica M Laronda; Thomas J Hope; Kruti P Maniar; Mary Ellen Pavone; Michael J Avram; Elizabeth C Sefton; Spiro Getsios; Joanna E Burdette; J Julie Kim; Jeffrey T Borenstein; Teresa K Woodruff
Journal:  Nat Commun       Date:  2017-03-28       Impact factor: 14.919

Review 10.  Organoid systems to study the human female reproductive tract and pregnancy.

Authors:  Lama Alzamil; Konstantina Nikolakopoulou; Margherita Y Turco
Journal:  Cell Death Differ       Date:  2020-06-03       Impact factor: 15.828

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.